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Background: Dysphagia is the important complication related to cerebral small vessel disease (CSVD) including lacunar in-
farcts (LIs), white matter hyperintensity (WMH), cerebral microbleeds (CMBs) and perivascular spaces (PVS). The aim of
this study was to investigate the relationship between swallowing function and CSVD.
Methods: This study is based on the authors’ prospective registry between 2015 and 2017. We enrolled 352 patients and
signs of CSVD on magnetic resonance imaging (MRI). Swallowing function was evaluated using the Repetitive Saliva Swal-
lowing Test and the Modified Water Swallow Test. On MRI, the severity of WMH including deep WMH (DWMH), the
number of LIs, CMBs and PVS were assessed.
Results: Seventy-nine out of 352 (24.4%) patients exhibited swallowing impairment. Mean age was 70.4±10.6 years and
218 were male (63.4%). Those with dysphagia had higher WMH scores and a greater number of LIs than those without. The
severity of whole WMH, frontal and parietal DWMH were associated with dysphagia. After adjustment for age, sex, vascular
risk factors, and Mini Mental State Examination, whole WMH severity still associated with dysphagia.
Conclusions: WMH, particularly frontal and parietal DWMH, was associated with swallowing impairment.
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Introduction
Post-stroke dysphagia has long been considered one of
several serious complications because it may lead to aspi-
ration pneumonia, malnutrition and mortality.
１
Cerebral
small vessel disease (CSVD) has attracted attention be-
cause it is believed to be associated not only with stroke
but also with dementia, gait disturbance, movement dis-
orders, urinary problems, dysphagia and mood disor-
ders.
２-７
However, despite substantial information regard-
ing concomitant CSVD in dysphagia in acute and chronic
stroke,
１，８
few studies have examined the relationship be-
tween asymptomatic CSVD and swallowing problems.
We investigate to clarify the association between each
CSVD subtype and swallowing impairment in apparently
healthy subjects including those with a history of stroke.
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Subjects with CSVD were recruited as part of the pro-
spective study known as the Tokyo Women’s Medical
University Cerebral Vessel Disease Registry. Consecu-
tive outpatients >40 years of age, with any cerebrovascu-
lar risk factor(s), including history of stroke, arterial hy-
pertension, diabetes mellitus, hyperlipidemia, coronary
artery disease or smoking, were recruited. Each subject
was able to independently perform activities of daily liv-
ing. Individuals with aphasia, impaired comprehension,
dementia, degenerative disorders, current stroke or un-
able to walk were excluded.
Enrolled participants underwent cranial magnetic reso-
nance imaging (MRI), Mini Mental State Examination
(MMSE) (score range 0 to 30)
９
and the Japanese version
of the Montreal Cognitive Assessment (MoCA-J) (score
range 0 to 30)
１０
to assess cognitive function. At enroll-
ment, we examined both cognitive function and swallow-
ing test at the same day. A total of 419 subjects were re-
cruited from October 2015 to July 2017. Of these partici-
pants, 352 underwent the Repetitive Saliva Swallowing
Test (RSST) and the Modified Water Swallowing Test
(MWST) to detect swallowing impairment. The 67 pa-
tients could not undergo the swallowing tests. We got in-
formed consents from all of subjects. The clinical trial
registration number; UMIN000026671.
2. MRI
All subjects underwent 1.5 Tesla or 3 Tesla brain MRI
within 1 year from being recruited to the registry. The
MRI protocol included the following sequences : T 1-
weighted imaging; T2-weighted imaging; T2*-weighted
imaging ; fluid-attenuated inversion recovery ( FLAIR )
imaging; and diffusion-weighted imaging.
White matter hyperintensity (WMH) severity consisted
of periventricular hyperintensity (PVH) and deep WMH
(DWMH), and were rated visually on axial FLAIR im-
ages using the modified Fazekas scale (0 =none; 1 =
mild; 2 = moderate; 3 = severe)
１１
(Figure 1) and the
Scheltens rating scale, in which scores 0 to 6 are assigned
to 13 subcortical regions (subcortical white matter, based
ganglia, and infratentorial region), and scores 0 to 2 for 3
periventricular regions.
１２
At first, we assessed each lateral hemisphere WMH by
original Fazekas and Scheltens scale. After that, we as-
sessed bilateral hemisphere WMH by addition of the
right and left scale. Bilateral Fazekas scale scores were
arranged into two or three groups : PVH or DWMH
Fazekas score was divided into two groups (0 to 2 =
mild; 3 to 6 = severe); and whole Fazekas score (PVH+
DWMH) was divided into three groups (0 to 3 = mild; 4
to 6 = moderate; and 7 to 12 = severe). On the other
hand, bilateral subcortical Scheltens scores ranged from 0
to 12 and were divided into three groups (0 = none; 1 to
6 = moderate; and 7 to 12 = severe) at each lobe (frontal,
temporal, parietal and occipital) WMH. To identify lacu-
nar infarcts (LIs), FLAIR, T2 images and T1 images
were used. The size of the LIs were defined from 3 mm
to 15 mm, and located in the surrounding white matter,
subcortical gray matter, thalamus, and brainstem. LIs
were also defined as hyperintensity on T2 images, hy-
pointensity on T1 images, and a hyperintense rim around
the cavity in FLAIR images, which could distinguish
from perivascular spaces (PVS). The number of whole
LIs were recorded as 0, 1, or > 2. Cerebral microbleeds
(CMBs) were identified in T2* images as size < 10 mm
low intensity and not with edema. The number of whole
CMBs was recorded as 0, 1, or > 2. PVS were similar
shape to LIs with hyperintensity on T2-images, but could
be distinguished from smaller LIs (< 3 mm), following
the vessel, shape resembling a spot or line, and without a
hyperintense rim on FLAIR. The number of PVS were
grouped as follows: none = 0; mild = 1 to 10; and severe
> 11. The CSVD subtypes were assessed by trained two
neurologists.
3. Swallowing function assessment
1) Repetitive Saliva Swallowing Test
The RSST is a screening test for swallowing function
proposed by Oguchi et al. in Japan.
１３
In the sitting posi-
tion, subjects are asked to swallow their own saliva as
many times as possible for 30 s. The examiner palpates
the subject’s larynx and counts the number of swallows.
Fewer than 3 swallows for the 30 s period is considered
to abnormal. The sensitivity and specificity of the RSST
was reported to be 0.98 and 0.66, respectively.




The MWST is another screening test for dysphagia.
Cold water (3 ml) was placed on the floor of the mouth
and the subject was instructed to swallow. If the subject
was unable to swallow, or experienced dyspnea, cough-
ing, or wet-hoarse dysphonia after swallowing, a score
was recorded (1 for inability to swallow, 2 for dyspnea,
and 3 for cough or dysphonia) and the test was termi-
nated. (Dyspnea was, defined as any complaint or obser-
vation of difficulty breathing in association with the
swallowing test. ) Otherwise, the subject was asked to
perform two dry (saliva) swallows. If the subject was
able to swallow the water but unable to perform either of
the two dry swallows, a score of 4 was recorded. If the
patient was able to complete the water and both dry swal-
lows within 30 s, a score of 5 was recorded. The entire
procedure was repeated twice more. The final score was
defined as the lowest score on any trial.
１４-１６
The sensitivity




Statistical analysis was performed using JMP version
13 (SAS Institute Inc., Cary, NC, USA); p < 0.05 was
considered to statistically significant. Demographic vari-
ables between patients with and without dysphagia were
compared using the Mann-Whitney U test or the χ2 test,
as appropriate. Multivariate logistic regression analysis
adjusted for age, sex, and any vascular risk factor ob-
tained in the univariate analysis, was performed to reveal
associations with dysphagia and MRI findings.
Results
Among the 352 patients, 218 were male (63.4%) and 134
were female (36.6%). The mean (± SD) age of the pa-
tients was 70.4±10.6 years, the median interval between
MRI imaging and swallowing test was 4 months and 3
(0.9%) were receiving anticholinergic drug with risk of
xerostomia but none of them complained of dry mouth or
―27―
swallowing problem.
Seventy-nine (22.4%) of subjects exhibited swallow-
ing impairment, including 63 ( 17.9% ) in RSST, 19
(5.3%) in MWST, and 3 (0.85%) in both. Patients with
swallowing impairment were older, had a higher systolic
blood pressure and glycated hemoglobin level, lower es-
timated glomerular filtration rate and more history of dia-
betes mellitus than those without swallowing impair-
ment. The incidence of swallowing impairment was
higher in patients with a history of stroke ( 49 / 181
[27.1%]) compared to those without a history of stroke
(30/171 [17.6%]). Both the MMSE and MoCA-J scores
were significantly lower in patients with swallowing
problems. In terms of each swallowing test, mean MMSE
were 26.3 ± 2.6 and 27.6 ± 2.6 (p < 0.001) and mean
MoCA-J were 21.6± 3.9 and 23.6± 3.6 (p < 0.001) in
patients with and without swallowing impairment in
RSST, respectively. In MWST test, mean MMSE were
25.6 ± 3.7 and 27.4 ± 2.5 ( p = 0.024 ) and mean
MoCA-J were 20.4± 4.0 and 23.4± 3.6 (p = 0.001) in
those with and without swallowing impairment, respec-
tively. In MRI findings, the total score of WMH lesions,
DWMH, and the number of LIs were significantly higher
in those with swallowing impairment than those without
(Table 1). Median score of total WMH lesions in sub-
jects with normal swallowing (n = 273), positive only for
RSST(n = 60) and positive only for MWST(n = 16) were
4(4, 5), 4(4, 6) and 4(4, 6) respectively (p = 0.003). The
difference between normal and positive only for RSST
was significant (p = 0.001) but MWST was not signifi-
cant (p = 0.112). The difference between positive only
for RSST and MWST was not significant (p = 0.786).
However, the number of CMB and PVS were similar be-
tween those with and without swallowing impairment.
The severity and number of WMHs, LIs, CMB and PVS
in relation to swallowing impairment are shown in Fig-
ure 2 and Figure 3. The grade of total WMH (PVH+
DWMH) score and DWMH score was significantly asso-
ciated with swallowing impairment (Figure 2). The asso-
ciation between PVH grade and swallowing impairment
demonstrated borderline significance (p = 0.058). How-
ever, no association was found between the grade of LIs,
CMBs, PVS and the prevalence of swallowing impair-
ment (Figure 3).
The association between WMH grade in various loca-
tions and swallowing impairment is shown in Figure 4.
A significant association was found between frontal and
parietal DWMH grade and swallowing impairment; how-
ever, no association was observed in the temporal and oc-
cipital DWMH.
The relationship between grade of WMH and DWMH
and swallowing impairment was assessed using logistic
regression analysis (Table 2). In the univariate model,
whole PVH+DWMH, DWMH, and DWMH in the fron-
tal and parietal lobes, increased the risk for swallowing
impairment. After adjustment for sex, age, diabetes, his-
tory of stroke and MMSE score, only whole PVH +
DWMH remained significantly associated.
Discussion
The two major findings of the present study were that
> 20% of patients with any CSVD findings on MRI, who
had subclinical dysphagia; and, among the CSVD sub-
types, only the severity of WMH, particularly DWMH in
the frontal and parietal lobes, was closely associated with
swallowing impairment.
Previous studies have examined the incidence of
dysphagia, but mostly in stroke patients.
８
Although the
present study also included 181 (52.3%) patients with a
history of stoke, it was surprising that approximately
20% of apparent healthy individuals without a history of
stroke, but with any sign of CSVD on MRI, exhibited a
swallowing impairment. Given that dysphagia is closely
related to aspiration pneumonia, malnutrition and mortal-
ity, swallowing impairment should warrant significant at-
tention in the management of patients with CSVD.
Among the CSVD subtypes, only WMH was inde-
pendently associated with swallowing impairment. The
number of LIs tended to reflect swallowing impairment,
but neither number of CMBs or PVS were related to
swallowing disorders. Fandler et al. reported that only
WMH―not CMBs or number of LIs―was related to
dysphagia in patients with recent small subcortical in-
farcts.
１８
Several previous studies have also reported that WMH
grade influences deglutition disorder(s). Kim et al. re-
ported that both brain stem abnormalities and paraven-
tricular WMH are associated with dysphagia.
１９
Both
Moon et al. and Levine et al. showed that prolonged oral
―28―
Figure　2　Relation of Fazekas score and swallowing impairment.
PVH, periventricular hyperintensity; DWMH, deep white matter hyperintensity.








Age (mean ±SD) 70.4 ± 10.6 69.1 ± 10.6 74.6 ± 9.21 <0.001
Female (n, (%)) 134 (36.6) 102 (37.4) 28 (8.0) 0.801
BMI, kg/m2 23.3 ± 3.5 23.3 ± 3.5 23.4 ± 3.7 0.980
Hypertension, % 232 (65.9) 177 (64.8) 55 (69.6) 0.426
 Systolic blood pressure, mmHg 134 ± 17.7 133.3 ± 17.5 137.0 ± 18.3 0.037
 Diastolic blood pressure, mmHg 73.8 ± 12.0 74.4 ± 12 72.0 ± 12.0 0.118
Dyslipidemia, % 176 (50) 143 (52.4) 33 (41.8) 0.097
 LDL cholesterol, mmol/l 2.76 ± 0.69 2.59 ± 1.00 2.47 ± 0.97 0.234
 HDL cholesterol, mmol/l 1.59 ± 0.53 1.52 ± 0.57 1.48 ± 0.78 0.095
 TG, mmol/l 1.38 ± 0.75 1.30 ± 0.70 1.51 ± 0.89 0.273
Diabetes, % 106 (30.1) 74 (27.1) 32 (40.5) 0.022
 FBS, mg/dl 120 ± 43.8 117.8 ± 40.1 127.1 ± 54.0 0.233
 HbA1c, % 6.6 ± 5.6 6.2 ± 1.0 6.5 ± 1.1 0.012
Chronic kidney disease, % 37 (10.5) 31 (11.4) 6 (7.6) 0.337
 Serum creatinin, mg/dl 1.0 ± 0.7 1.0 ± 0.8 1.0 ± 0.3 0.097
 eGFR, ml/min/1.73 m2 59.8 ± 16.3 60.9 ± 17.6 56.1 ± 12.4 0.006
 Proteinuria, % 43 (15.6) 28 (14.5) 13 (16.5) 0.268
Atrial fibrillation, % 35 (9.9) 27 (9.9) 8 (10.1) 0.951
Current smoking, % 23 (6.7) 16 (6.0) 7 (9.3) 0.312
History of stroke, % 181 (52.3) 132 (49.3) 49 (62.8) 0.035
 Ischemic stroke, % 156 (44.3) 114 (41.7) 42 (53.2) 0.072
 Transient ischemic attack, % 27 (7.7) 22 (8.1) 5 (6.3) 0.611
 Cerebral hemorrhage, % 9 (2.6) 6 (2.2) 3 (3.8) 0.428
Previous history of pneumonia, % 5 (1.4) 4 (1.5) 1 (1.4) 0.902
Use of anticholinergic drugs 3 (0.9) 2 (0.7) 1 (1.3) 0.650
MMSE (pt) 27.3 ± 2.6 27.7 ± 2.4 26.2 ± 2.9 <0.001
MoCA-J (pt) 23.2 ± 3.7 23.8 ± 3.4 21.3 ± 4.0 <0.001
MRI findings
Fazekas-PVH+DWMH (median, IQR) 4 (4,6) 4 (4,5) 4 (4,6) <0.001
Fazekas-PVH (median, IQR) 2 (2,3) 2 (2,2) 2 (2,2) 0.046
Fazekas-DWMH (median, IQR) 2 (2,3) 2 (2,3) 2 (2,4) <0.001
Lacuna infarcts (n, median, IQR) 0 (0,1) 1 (0,2) 1 (0,3) 0.041
Cerebral microbleeds (n, median, IQR) 2.5 (0,6) 0 (0,1) 0 (0,1) 0.968
Perivascular space (n, median, IQR) 1 (0, 2) 2 (0,6) 3 (1,8) 0.194
RSST (median, IQR) 4 (3,6) 5 (4,7) 2 (2,2) <0.001
MWST (pt median, IQR) 5 (5,5) 5 (5,5) 4 (4,5) <0.001
BMI, body mass index; TG, triglyceride; FBS, fasting blood sugar; HbA1c, hemoglobin A1c; eGFR, estimate glomerular filtration. Data 
represent no. (%), mean (SD) or median (interquartile range).
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Figure　3　Relation of dysphagia and lacunar infarcts (LI), cerebral microbleeds (CMBs) and perivas-
cular spaces (PVS).
Figure　4　Relation of dysphagia and Scheltens WMH score.
WMH, white matter hyperintensity; DWMH, deep WMH.
transit duration in elderly patients was related to the se-
verity of Fazekas PVH grade.
２０，２１
They speculated that se-
vere PVH led to dysphagia due to insufficient function of
the neural network and cognitive decline.
２２
Results of our
study also suggest that cognitive function is related to
swallowing impairment (Table 1).
Our study showed that DWMH in the frontal and pa-
rietal lobe may be involved in swallowing impairment.
To discuss any relationship between lesion location and
swallowing, however, it is important to consider swal-
lowing physiology and anatomical circuitry.
Swallowing is a complex, controlled, sensory-motor
system consisting of 3 phases: the oral phase; the oral
preparatory and transfer phase, he pharyngeal and
esophageal phase. In the oral preparatory phase, foods
and/or drinks are recognized by the visual and olfactory
―30―
Figure　5　Neural activation of swallowing proceeds frontal lobe in oral phase, cortico-bulbar tract 
and brainstem in pharyngeal and esophageal phase. Subcortical areas and limbic system influence fron-
tal lobe activation. Frontal DWMH may inhibits these neural activation circuit.
DWMH, deep white matter hyperintensity.
Table　2　Odds ratio of unadjusted and adjusted for age, sex, diabetes mellitus, presence of stroke and MMSE.
WMH score n
Unadjusted Adjusted
OR (95% CI) p value OR (95% CI) p value
Fazekas PVH+DWMH
 0-3  51 1.00 (reference) 1.00 (reference) 
 4-6 245 16.2 (2.19-119.91) 0.006 11.49 (1.52-86.81) 0.018
 7-12  56 23.68 (3.03-185.33) 0.003 11.42 (1.39-93.56) 0.023
Fazekas DWMH
 0-2 252 1.00 (reference) 1.00 (reference) 
 3-6  99 1.80 (1.06-3.06) 0.030 1.38 (0.78-2.45) 0.274
Frontal-DWMH score
 0  44 1.00 (reference) 1.00 (reference) 
 1-6 222 4.28 (1.27-14.39) 0.019 3.30 (0.93-11.70) 0.065
 7-12  85 5.51 (1.56-19.5) 0.008 3.10 (0.92-13.00) 0.067
Parietal-DWMH score
 0 107 1.00 (reference) 1.00 (reference) 
 1-6 222 2.17 (1.16-4.04) 0.015 1.55 (0.81-3.03) 0.183
 7-12  23 2.16 (0.74-6.37) 0.161 1.16 (0.32-3.46) 0.925
MMSE, mini mental status examination; WMH, white matter hyperintensity; PVH, periventricular hyperintensity; 
DWMH, deep WMH.
senses. They are taken into the mouth, chewed, and
mixed with saliva to prepare for swallowing. In the oral
transfer phase, the tongue transfers chewed foods and
drinks to the pharynx. Some areas of the cortex and lim-
bic system are more activated in the oral phase and con-
trol the pharyngeal phase.
２３
The brainstem controls the in-
voluntary pharyngeal and esophageal phases through
several complex neuromuscular movements. The acti-
vated area of the brain is different among the normal
swallowing phases.
Several studies have demonstrated the involvement of
the cortico-bulbar tract,
２４
primary motor cortex, corona
radiata, internal capsule, and cerebral peduncle
２５，２６
in
dysphagia. Other cortical areas, such as the insula, pre-
motor gyrus, inferior frontal gyri, frontal operculum, and
anterior/posterior cingulate cortex, are also activated dur-
―31―
ing swallowing to control the oral preparatory and oral
transfer phases of normal deglutition.
２７，２８
These numerous
neural circuits activated during swallowing are in the
frontal lobe. This may explain why DWMH severity in
the frontal lobe influenced swallowing impairment in the
present study (Figure 5). Our study found that the sever-
ity of parietal DWMH was also associated with swallow-
ing impairment. Because patients with higher parietal
DWMH score also had higher frontal DWMH scores (p<
0.001) , the analysis between the parietal DWMH and
dysphagia may be similar in analysis of frontal DWMH.
There were several limitations to our study. First, the
RSST and the MWST could not detect which stage of
swallowing was impaired in individual patients. Other
deglutition tests such as videofluoroscopic study or
Toronto Swallow Assessment, Yale Swallow Screen or
the Barnes Dysphagia Assessment have been employed
for detail assessment of dysphagia in stroke patients.
２９
Because individuals enrolled in this study are all outpa-
tients and swallow normally, we employed RSST and
MWST as easy, quick and noninvasive swallowing
screening tests. Second, the interval between MRI imag-
ing and swallowing tests was long. Third, it remains un-
clear whether swallowing impairment detected in our
study could be a risk for future aspiration or pneumonia;
however, our prospective follow-up study may clarify
this point.
Conclusion
In conclusion, WMH severity, especially DWMH in the
frontal and parietal lobes, was associated with swallow-
ing impairment. Problems with swallowing represent
some of the most important symptomatic aspects found
in patients with CSVD.
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